Protagenic Property Plant Equipment from 2010 to 2024

PTIX Stock  USD 0.73  0.08  12.31%   
Protagenic Therapeutics Property Plant Equipment yearly trend continues to be fairly stable with very little volatility. Property Plant Equipment will likely drop to 253.08 in 2024. During the period from 2010 to 2024, Protagenic Therapeutics Property Plant Equipment regression line of annual values had r-squared of  0.40 and arithmetic mean of  666.83. View All Fundamentals
 
Property Plant Equipment  
First Reported
2010-12-31
Previous Quarter
266.4
Current Value
253.08
Quarterly Volatility
455.01049462
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Protagenic Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Protagenic Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 26.8 K, Interest Expense of 87.3 K or Selling General Administrative of 1.1 M, as well as many indicators such as Price To Sales Ratio of 0.28, Dividend Yield of 0.0 or PTB Ratio of 1.11. Protagenic financial statements analysis is a perfect complement when working with Protagenic Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Protagenic Therapeutics Correlation against competitors.
For more information on how to buy Protagenic Stock please use our How to Invest in Protagenic Therapeutics guide.

Latest Protagenic Therapeutics' Property Plant Equipment Growth Pattern

Below is the plot of the Property Plant Equipment of Protagenic Therapeutics over the last few years. It is Protagenic Therapeutics' Property Plant Equipment historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Protagenic Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Property Plant Equipment10 Years Trend
Slightly volatile
   Property Plant Equipment   
       Timeline  

Protagenic Property Plant Equipment Regression Statistics

Arithmetic Mean666.83
Geometric Mean0.00
Coefficient Of Variation68.23
Mean Deviation402.69
Median611.00
Standard Deviation455.01
Sample Variance207,035
Range1.6K
R-Value(0.64)
Mean Square Error132,858
R-Squared0.40
Significance0.01
Slope(64.68)
Total Sum of Squares2.9M

Protagenic Property Plant Equipment History

2024 253.08
2023 266.4
2019 296.0
2018 611.0
2017 1022.0
2016 1097.0
2015 1569.0

About Protagenic Therapeutics Financial Statements

Protagenic Therapeutics investors use historical fundamental indicators, such as Protagenic Therapeutics' Property Plant Equipment, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Protagenic Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Property Plant Equipment 266.40  253.08 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Protagenic Stock Analysis

When running Protagenic Therapeutics' price analysis, check to measure Protagenic Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagenic Therapeutics is operating at the current time. Most of Protagenic Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protagenic Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagenic Therapeutics' price. Additionally, you may evaluate how the addition of Protagenic Therapeutics to your portfolios can decrease your overall portfolio volatility.